Well could be exciting times ahead as we cracked the first deal with St Vincents and more will follow - St Vincents are familiar and a great opportunity to get our stamp of approval - more will follow so onwards and upwards from here - might not get back to $1.00 this week but im sure in 12 months could be a different game
MD said more deals to follow this year so stay tuned and get in for the long haul to some re-rating finally and bit more notoriety in this sector - World first in AI testing to speed up efficiency of tests across a massively growing market for speeding up results - ill be buying a few more for the war chest today
Note: we also recently got some coverage from Simply Wall Street on 03 July 2018 asking that all elusive question - What are we worth???
Is It Time To Buy LBT Innovations Limited (ASX:LBT)?
Kristin Rankin July 3, 2018
LBT Innovations Limited (ASX:LBT), a medical equipment company based in Australia, received a lot of attention from a substantial price movement on the ASX over the last few months, increasing to A$0.15 at one point, and dropping to the lows of A$0.098. This high level of volatility gives investors the opportunity to enter into the stock, and potentially buy at an artificially low price. A question to answer is whether LBT Innovations’s current trading price of A$0.10 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at LBT Innovations’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.See our latest analysis for LBT Innovations
What is LBT Innovations worth?
Good news, investors! LBT Innovations is still a bargain right now. In this instance, I’ve used price-to-book ratio (PB) ratio given that there is not enough information to reliably forecast the stock’s cash flows, and its earnings doesn’t seem to reflect its true value. I find that LBT Innovations’s ratio of 0.68x is below its peer average of 3.75x, which suggests the stock is undervalued compared to the Medical Equipment industry. LBT Innovations’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach its true value, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.
What does the future of LBT Innovations look like?
ASX:LBT Future Profit July 3rd 18
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With revenues expected to grow by 47.05% over the next couple of years, the future seems bright for LBT Innovations. If the level of expenses is able to be maintained, it looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? Since LBT is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.
Are you a potential investor? If you’ve been keeping an eye on LBT for a while, now might be the time to make a leap. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy LBT.
Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on LBT Innovations.
You can find everything you need to know about LBT Innovations in the latest infographic research report. If you are no longer interested in LBT Innovations, you can use our free platform to see my list of over 50 other stocks with a high growth potential.
(20min delay)